Chardan Capital Markets Downgrades Intellia Therapeutics (NTLA) to Neutral Aug 29, 2017 03:20AM
Chardan Capital Markets Upgrades Akari Therapeutics (AKTX) to Neutral May 31, 2017 04:55AM